Center them. Gamalei developed a version of "Sputnik V" against strains "delta" and "omicron"

This is stated in the press service of the fund.

It is noted that a new version of the vaccine was created taking into account the characteristics of these strains.

The report clarifies that the adapted Sputnik V vaccine provides a significant reduction in viral load in the lungs of animals.

Earlier, the head of the Gamaleya Center, Alexander Gintsburg, said that the Russian vaccine against coronavirus infection is 3-3.5 times more effective than Western ones.